Skip to main navigation Skip to search Skip to main content

Diagnostic applications of nuclear medicine: Sarcomas

  • University of Texas MD Anderson Cancer Center
  • Seattle Children's
  • St. Jude Children Research Hospital

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Bone and soft tissue tumors, while rare, account for a relatively large proportion of pediatric cancer diagnoses. The role for [18F]FDG PET/CT in the staging and prognostication of pediatric s arcomas remains an active area for research and topic of debate. [18F]FDG PET/CT clearly maintains a significant role in the detection of osseous metastasis in osteosarcoma, Ewing sarcoma, and rhabdomyosarcoma; however, it lacks the sensitivity and specificity in detecting pulmonary metastasis when compared to conventional CT scan. [18F]FDG PET/CT predicts histologic response in osteosarcoma; however, more studies are needed to determine whether it can predict outcome in other pediatric sarcomas as a whole. While [18F]FDG PET/CT is becoming increasingly utilized in the staging of pediatric sarcomas, more research will be needed to fully understand how best to incorporate its use in the management of, or as a prognostic tool in, pediatric and young adult bone and soft tissue sarcomas.

Original languageEnglish
Title of host publicationNuclear Oncology
Subtitle of host publicationFrom Pathophysiology to Clinical Applications
PublisherSpringer International Publishing
Pages1213-1234
Number of pages22
ISBN (Electronic)9783031054945
ISBN (Print)9783031054938
DOIs
StatePublished - 4 Oct 2022
Externally publishedYes

Keywords

  • Ewing
  • Malignancy
  • Osteosarcoma
  • Outcome
  • Pediatric
  • PET/CT
  • Rhabdomyosarcoma
  • Sarcomas
  • Staging
  • [F]FDG

Fingerprint

Dive into the research topics of 'Diagnostic applications of nuclear medicine: Sarcomas'. Together they form a unique fingerprint.

Cite this